Pritelivir met its primary endpoint of superior lesion healing, achieving a 62.7% lesion healing rate compared to 34.0% with standard-of-care therapies (investigator’s choice), resulting in an ...
AstraZeneca is taking its oral GLP-1 drug into phase 3 on the back of a pair of midstage weight loss wins, despite remaining tight-lipped on how the candidate actually performed. The U.K.-based Big ...
Humble brag: I reckon I could spot a fitness gimmick a mile off. As WH’s Fitness Editor, I spend pretty much all day everyday reading/writing about the latest workout trends. I’m also kind of addicted ...
Rahul Nambiampurath has been writing and reporting about cryptocurrency since 2017. As a fan of decentralized tech, he was fascinated by the Bitcoin whitepaper. Erika Rasure is globally-recognized as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results